Senores Pharmaceuticals acquires ANDAs from Teva Pharmaceuticals USA
The acquired ANDAs represent a market opportunity of about US$ 38 million in the USA
The acquired ANDAs represent a market opportunity of about US$ 38 million in the USA
Marksans Pharma gets USFDA nod for acid reflux drug
FDA grants accelerated approval to zongertinib for HER2 TKD-Mutated Non-Squamous NSCLC
The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), KENGREAL of Chiesi USA
NJ Bio is currently executing a major new program for an existing innovator customer with multiple ADC candidates in their pipeline
Quest will now offer dialysis-related clinical testing services to independent dialysis clinics
IOLCP has reported total income of Rs. 559.06 crores during the period ended June 30, 2025
The partnership aims to co-develop technologies set to revolutionize manufacturing of plasmid DNA (pDNA), a critical raw material for advanced medicines
Subscribe To Our Newsletter & Stay Updated